EU Biosimilar Filings, Opinions & Approvals

New biosimilar product filings for review by the European Medicines Agency’s human medicines committee (the CHMP), CHMP opinions, withdrawals of applications and decisions on biosimilar marketing authorizations by the European Commission. Updated monthly.

Click on any column header to sort by that topic. The search box can be used to filter results.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".